Baseline diabetic status and admission blood glucose were poor prognostic factors in the EPITHET trial

- De Silva, D. A., Ebinger, M., Christensen, S., Parsons, M. W., Levi, C., Butcher, K., Barber, P. A., Bladin, C., Donnan, G. A., Davis, S. M.

Ischemic diffusion lesion reversal is uncommon and rarely alters perfusion-diffusion mismatch

- Chemmanam, T., Campbell, B. C. V., Davis, S. M., Christensen, S., Nagakane, Y., Desmond, P. M., Bladin, C. F., Parsons, M. W., Levi, C. R., Barber, P. A., Donnan, G. A.

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

- Lees, Kennedy R., Bluhmki, Erich, Tilley, Barbara C., Davis, Stephen M., Donnan, Geoffrey A., Hacke, Werner, ECASS, ATLANTIS, NINDS, and EPITHET rt-PA Study Groups, Allen, K., Mau, J., Meier, D., Del Zoppo, G., De Silva, D. A., von Kummer, Rudiger, Butcher, K. S., Parsons, M. W., Barber, P. A., Levi, C., Bladin, C., Byrnes, G., Brott, Thomas G., Toni, Danilo, Grotta, James C., Albers, Gregory W., Kaste, Markku, Marler, John R., Hamilton, Scott A.

Refining the perfusion-diffusion mismatch hypothesis

- Butcher, K. S., Parsons, M., Tress, B., Donnan, G., Davis, S., MacGregor, L., Barber, P. A., Chalk, J., Bladin, C., Levi, C., Kimber, T., Schultz, D., Fink, J.